English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduISPOR—The Professional Society for Health Economics and Outcomes Research announced its new Strategic Plan 2030 that presents a bold new vision for the Society and the field of health economics and outcomes research (HEOR).
Tag: ISPOR
ISPOR International Panel Calls for Consensus on Medication Adherence Measures
ISPOR—The Professional Society for Health Economics and Outcomes Research announced the publication of a new report from the ISPOR Medication Adherence and Persistence Special Interest Group revealing significant inconsistencies in how researchers measure the effectiveness of interventions aimed at improving medication adherence. The report, “A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report” was published in the February 2024 issue of Value in Health.
ISPOR Launches New HEOR Learning Platform
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced today that it has launched its new online learning platform for HEOR education and training—ISPOR Education Center.
ISPOR Announces New Chief Science Officer
ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that Laura Pizzi, PharmD, MPH will be assuming the role of Chief Science Officer at the Society. ISPOR’s previous Chief Science Officer, Richard J. Willke, PhD, will be retiring.
Expert Panel Publishes Good Practices Recommendations for the Selection, Development, and Modification of Health-Related Performance Outcome Assessments
Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of an ISPOR Good Practices Report providing recommendations on performance outcome (PerfO) assessments.
ISPOR Highlights the Impact of Health Economics and Outcomes Research With New Microsite
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced today that it has launched a new “Impact of HEOR” microsite that highlights case illustrations from around the globe.
ISPOR Announces 2023-2024 Board of Directors
ISPOR—The Professional Society for Health Economics and Outcomes Research announced the results of its recent elections. The Society’s membership selected its new president-elect and 3 new board members.
ISPOR Publishes Report on Health Economics and Outcomes Research in Low- and Middle-Income Countries
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced that it has published a new report on its work in low- and middle-income countries (LMICs).
Global Expert Panel Publishes New Guidance on Measurement Comparability Between Methods of Patient Data Collection Recommending Move Away from Additional Testing
Value in Health, the official journal of ISPOR, announced today the publication of an ISPOR Good Practices Report providing recommendations for assessing the need to demonstrate comparability among ways to collect patient responses.
ISPOR Marks 25th Anniversary of Flagship Journal Value in Health
Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), published an editorial celebrating its 25th anniversary as the Society’s flagship HEOR journal.
Global Expert Panel Publishes New Guidance on Designing, Conducting, and Analyzing Quantitative Benefit-Risk Assessment
Value in Health, the official journal of ISPOR, announced the publication of new good practice guidelines for the design, conduct, analysis, and communication of quantitative benefit-risk assessments (qBRA) to support regulatory decision making of medical products.
ISPOR Announces New CEO
ISPOR—The Professional Society for Health Economics and Outcomes Research announced that its Board of Directors has appointed Rob Abbott as the Society’s new CEO and executive director after an extensive search process. Mr Abbott will assume the role of ISPOR’s CEO on March 13, 2023, succeeding Nancy S. Berg who is retiring.
ISPOR Publishes New Guidance on Designing and Conducting Patient Preference Studies
Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a new ISPOR Good Practices Report on patient-preference studies and introduces the ISPOR Roadmap for Patient Preferences in Decision Making,
Global Experts Introduce Strategic Action Plan to Accelerate Patient Access to Next-Generation DNA Sequencing in Oncology
Value & Outcomes Spotlight, the health economics and outcomes research (HEOR) news magazine of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a supplement, “A Plan of Action: Accelerating Patient Access to Next-Generation Sequencing in Oncology.”
ISPOR Announces Honorees for the 2022 Health Economics and Outcomes Research Awards
ISPOR—The Professional Society for Health Economics and Outcomes Research announced the recipients of its 2022 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.
Global Health Panel Publishes New Research Highlighting Ambiguity in Digital Health-Related Definitions
Value in Health, the official journal of ISPOR, announced the publication of a new report examining digital health terms and their definitions from the perspective of their applicability for outcomes research.
ISPOR Latin America Summit 2021 Announced
ISPOR—The Professional Society for Health Economics and Outcomes Research announced that its Virtual ISPOR Latin America Summit 2021 will be held 30 September to 1 October.
Laura T. Pizzi, PharmD, MPH Joins ISPOR as Associate Chief Science Officer
ISPOR—The Professional Society for Health Economics and Outcomes Research announced that Laura T. Pizzi, PharmD, MPH has joined the Society’s leadership team as Associate Chief Science Officer.
ISPOR Announces 2021-2022 Board of Directors
ISPOR—The Professional Society for Health Economics and Outcomes Research announced the results of its recent elections and its 2021-2022 Board of Directors.
ISPOR Launches HEOR Solutions Center
ISPOR—The Professional Society for Health Economics and Outcomes Research announced that it has launched its new HEOR Solutions Center.
ISPOR’S Value in Health Regional Issues Accepted Into Web of Science Core Collection
ISPOR—the professional society for health economics and outcomes research announced today that its regionally focused journal, Value in Health Regional Issues, has been selected for inclusion in the Web of Science.
ISPOR Announces New HEOR Excellence Award for Researchers in Low- and Middle-Income Countries
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced a new HEOR Scientific Achievement Award for individuals in low- and middle-income countries. All of ISPOR’s HEOR Awards are now open for nominations
ISPOR Launches Signal—A New Signature Program
ISPOR is launching a new, signature program—Signal— that will feature a series of conversations with speakers focused on latest research, new ideas, pressing issues, controversial topics, and emerging challenges that will define the next decade of healthcare decision making. The inaugural event will be held April 27, 2021.
ISPOR Science Strategy
The ISPOR Science Strategy has identified a targeted set of themes that the Society believes will have the greatest impact on both the field of HEOR and global healthcare.
ISPOR Releases Its New Science Strategy
ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that it has released its Science Strategy—a multiyear blueprint that will guide the Society’s efforts and mission-focused initiatives.
Virtual ISPOR Europe 2020 Program and Speakers Announced
ISPOR—The Professional Society for Health Economics and Outcomes Research announced its plenary sessions and speakers for Virtual ISPOR Europe 2020
ISPOR’s Real-World Evidence Transparency Initiative: Creating a Road Map That Builds Trust
ISPOR, the professional society for health economics and outcomes research announced a publication from the Real-World Evidence Transparency Initiative to encourage routine registration of noninterventional real-world evidence studies.
ISPOR Introduces New Competencies Framework for Health Economics and Outcomes Research Professionals
ISPOR—the professional society for health economics and outcomes research (HEOR), announced the publication of its HEOR Competencies Framework™ that was published in the September 2020 issue of Value in Health.
Coming of Age: Emerging Health Preference Research Based on Established Scientific Standards
Value in Health, the official journal of ISPOR, announced today the publication of a series of articles focused on recent developments in the field of health preference research.
New Editors-in-Chief Appointed for ISPOR’s Value & Outcomes Spotlight Magazine
ISPOR, the professional society for health economics and outcomes research (HEOR), announced the appointment of 2 new Editors-in-Chief for its HEOR news magazine, Value & Outcomes Spotlight.
ISPOR Working Group Provides a First-Ever Cross-Stakeholder Consensus Definition of “Patient Engagement in Research”
Value in Health announced the publication of results of an ISPOR systematic review and analysis resulting in a proposed definition of “patient engagement in research.”
ISPOR Announces 2020-2021 Board of Directors
ISPOR—The Professional Society for Health Economics and Outcomes Research announced the results of its recent elections and its 2020-2021 Board of Directors.
Innovative Approaches to Cost-Effectiveness Analysis in Healthcare
ISPOR—The Professional Society for Health Economics and Outcomes Research held its third and final Virtual ISPOR 2020 plenary session this afternoon, “On the Road to Enhanced Cost-Effectiveness Analysis—New Directions, New Milestones.”
Incorporating Patients’ Perspectives in the Medical Device Regulatory Process
Value in Health announced today the publication of an article highlighting US Food and Drug Administration (FDA) guidance and lessons learned regarding the use of patient preference information for FDA decision making about medical devices.
ISPOR Value of Information Task Force Publishes Two New Good Practices Reports
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of 2 Good Practices Reports that provide consensus guidance on Value of Information Analysis.
ISPOR Top 10 HEOR Trends Webinar Announced
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced a new webinar on its ISPOR 2020 Top 10 HEOR Trends report. The free webinar will be held Thursday, March 26, 2020 at 11:00AM EDT and is available for both members and nonmembers.
ISPOR-FDA Summit 2020 Will Focus on the Use of Patient-Preference Information in Medical Devices
ISPOR—the professional society for health economics and outcomes research, announced that it will be holding a joint ISPOR-FDA Summit, “Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond,” on March 31, 2020 in Silver Spring, MD, USA.
ISPOR’s Value in Health Regional Issues Names New Editor-in-Chief
ISPOR—the professional society for health economics and outcomes research, announced today that Manuel Antonio Espinoza, MD, MSc, PhD has been named editor-in-chief of Value in Health Regional Issues, the official regional journal of the Society.
ISPOR Publishes 2020 Top 10 Health Economics and Outcomes Research (HEOR) Trends Report
ISPOR—the professional society for health economics and outcomes research (HEOR), announced the publication of its 2020 Top 10 HEOR Trends report. In the report, the Society has identified the top 10 HEOR trends that will shape the field and influence healthcare over 2020 and the near future.
Big Data Offer Opportunity for Research and Learning in Healthcare
ISPOR, the professional society for health economics and outcomes research—held its third plenary session at ISPOR Europe 2019, “Big Data Healthcare: Endless Opportunities for Research and Learning,” this morning.
ISPOR Europe 2019 Convened 5500 Healthcare Stakeholders to Discuss the Digital Transformation of Healthcare
ISPOR, the professional society for health economics and outcomes research (HEOR), concluded its ISPOR Europe 2019 conference yesterday in Copenhagen, Denmark.
Is the Subscription-Based Model for Drug Reimbursement the Future?
ISPOR, the professional society for health economics and outcomes research—explored the topical issue of the subscription-based model for drug reimbursement this morning during the session, “Subscription-Based Model for Drug Reimbursement: A Fad or the Future?, at ISPOR Europe 2019.
How Addressing Inefficiency in Health Systems Could Spur Innovation and Provide Real Value to Patients
ISPOR, the professional society for health economics and outcomes research—explored the issue of wasted healthcare spending and how to improve health system efficiencies in the session, “How Can We Create Headroom for High-Value Care By Increasing Efficiency in Health Systems?.”
Reshaping Healthcare Through Technology to Deliver Better Patient Care
ISPOR, the professional society for health economics and outcomes research—second plenary session at ISPOR Europe 2019, “Shaping the Digital Healthcare System,” was held this morning in Copenhagen, Denmark.
Has the Time Come for Pharma to Accept Modest Prices?
ISPOR, the professional society for health economics and outcomes research—explored the issue of drug pricing in the session, “Time for Change? Has the Time Come for the Pharma Industry to Accept Modest Prices?.”
Evaluating Digital Health Technologies
ISPOR, the professional society for health economics and outcomes research—explored the potential of digital health technologies to address key health-related challenges and how to best evaluate these technologies as the field evolves.
ISPOR Announces Its Strategic Plan Update 2024
ISPOR—the professional society for health economics and outcomes research—announced today its Strategic Plan Update 2024.